Welcome
Company Overview
Core Principles
Board of Directors
OpGen Team
Investor Relations
Terms of Use
Privacy
 
 
 
  Overview
What Is Optical Mapping?
MapSolver™
Comparative Genomics
Whole Genome Sequence Assembly
Strain Typing
Food Microbiology
Epidemiology / Food Safety
Bibliography
 
 
 
  Careers at OpGen
Our Culture
Employee Benefits
 
 
 
  Argus® Optical Mapping System
MapIt® Services
- Sample Preparation
- Sample Transport
- Request a MapIt Quote
- Payment + Terms
 
 
 
  Customer Support
FAQ
Resource Downloads
Optical MapDemos
 
 
 
  Press Releases/Media
Calendar, Tradeshows & Events
 
 
 
  Corporate
Distributor Partners
Directions to OpGen, Inc.
 
 

OpGen: Board of Directors

Evan Jones, Executive Chairman

Evan is the Managing Member of jVen Capital, LLC, a life sciences investment company. Prior to forming jVen Capital, Evan was co-founder, Chairman and CEO of Digene Corporation, a publicly traded biotechnology company focused on women’s health and molecular diagnostic testing. Digene was sold to Qiagen N.V. in July 2007 for $1.6 billion.

Evan has 25 years of operating and investment experience in the life sciences industry where he founded or helped start numerous life sciences companies. Currently, Evan serves as Chairman of the Board of Signature Genomic Laboratories LLC and as a Board Member of CAS Medical Systems, Inc., Opgen, Inc., and Veracyte, Inc. Additionally, Evan serves as Chairman of the Board for the Campaign for Public Health, an organization dedicated to the CDC annual budget, and as a member of the Board of Directors and the Executive Committee of Research! America. Past service includes Chairman of the Board of the Children’s Research Institute and as a Board Member for the Children’s National Medical Center.

Evan has a BA degree from the University of Colorado and an MBA from The Wharton School, University of Pennsylvania.